Will The Coronavirus Go Away Without a Vaccine?

Pandemics are nothing new. The Old Testament, in the books of Leviticus and Numbers, addresses the unclean and contagious nature of leprosy and provides details on how to quarantine lepers. In the fourteenth century, the world was ravaged by “the Black Death”, a bubonic plague that first originated from Asia and spread to the Mediterranean, to unleashed horrific devastations all over Europe. Despite lacking any advanced knowledge of microbes or theories of disease transmission, Venice’s local authorities managed to link the origin of the disease to a boat that had entered the port and devised containment measures of those who were contaminated. That was the introduction of the “quaranta”, a forty-day period of confinement, which was established at that time, as the length of time necessary to certify entrants as medically safe.

But for some weird reason, in the face of today’s pandemic we would not consider quarantining only the sick. The “modern” approach of quarantine is about confining the general population. Which of course, is unsustainable. Therefore, short of being able to confine healthy people forever, the next beloved idea is to mass treat it with vaccination.

But it’s not that easy. Back in the 80’s, at the height of the HIV pandemic, US Secretary of Health and Human Services Margaret Heckler predicted that a preventative vaccine would be ready for testing in two years. As we know, it never materialized.

We’ve learned from past epidemics that as people get sick in the short term their immune system develops antibodies to fight the illness. In the long term this provides immunity for the affected population. This immunity limits person to person viral transmission. This is called “community” or herd immunity. It works but it can take years to achieve.

The fact is that the virus could remain with us for many years. In the meantime, the medical response to HIV/AIDS, for which a vaccine was never achieved, provides a framework for living with a disease may look like: The development of therapeutic treatments will help “flatten the curve” of new cases over time, and we will learn to live with the idea that the virus is “out there”. Developing new drugs for COVID-19 takes longer than getting approval for an existing drug, but the windfall for pharmaceutical companies developing new drugs is such, that there is a strong push back against the idea of considering anything old or natural (in other words, everything that cannot be patented). We will therefore wait for new drugs approval. The Federal Drug Administration is poised to speed it up by fast-tracking some approvals to treat those who get sick. The new norm for society will become continuing social distancing, as well as having a big number of our freedoms limited.

However, most experts remain confident that we will see the COVID-19 vaccine being developed in the coming months; in part because, the coronavirus does not mutate rapidly, making it a good candidate, at least on paper, for vaccination, and also because there is so much at stake financially and politically that pharmaceutical companies are under extreme pressure “to come up with something”.


Not all vaccines are effective. Actually, the CDC indicates that flu vaccine effectiveness has oscillated between 10-60% from 2005-2017, while systematic reviews show no beneficial effect of inactivated influenza vaccines on flu mortality.(1) Moreover, vaccines for the common flu (rhinoviruses and adenoviruses)—which, like the coronavirus, can cause cold symptoms—are known to be very difficult to develop. However, it is clear that even if a vaccine doesn’t work as well as advertised, chances are that low immunity will be considered better than no immunity. Considering the political pressure to provide the general population with a sense of security, any vaccine providing some level of immunity will be hailed as a victory against the pandemic.

Even though concerns over the need for more effective vaccines will be dismissed, a potential problem for vaccines that induce low levels of antibodies should not be ignored. A phenomenon called “antibody-dependent enhancement of disease”, is where the low level antibodies induce a more invasive spread of the virus into different cell types, actually worsening the disease. This is exactly what was seen in clinical trials when the science was abandoned for the HIV vaccine.

Research on the long term effects of not-so-effective vaccines reveal that even with 100% compliance, outbreaks would still occur because the vaccines would not provide the population with sufficient immunity to prevent epidemics.(2)


From recent data (3), researchers are able to compare the results obtained by countries having enforced a strict lock down (like France, Ireland, Italy, Belgium and the UK), to those who have opted for a “smart lock down” (like the Netherlands, where only activities requiring close contact with clients, as well as bars and restaurants, were ordered to close down), to those who opted for no lock down at all, only social distancing (Sweden), it is becoming increasingly clear that the lock down has failed to translate into a reduced mortality rate of COVID-19.

Sweden and Ireland have had similar mortality rates as a result of COVID-19, while the former allowed commercial activities to continue and the latter imposed strict containment. On the other hand, Eastern Europe is much less affected than Western countries, including the United States. This can be explained by the fact that the countries of Western Europe and the United States have areas of urban concentration with high population densities and many international airports.

Additional differences like demographics (ageing and multicultural societies) and health (obesity and diabetes) can also explain why some countries have rates of less than ten per million, while Western Europe and the USA are in the hundreds.

Finally, it is important to keep in mind that all those numbers are not absolutely reliable, as significant differences in diagnostic practice and recording have been observed around the world.

Belgium has the highest COVID-19 mortality rate in the world, at 763 per million, while Denmark and Germany are faring much better.

When researchers decided to compare the data with a map of the flu vaccination their findings were sobering. Pediatrician Alan Cunningham explains: “Such an observation may seem counter-intuitive, but it is possible that influenza vaccines alter our immune systems non-specifically to increase susceptibility to other infections; this has been observed with DTP and other vaccines.”(4)

It turns out that the countries with highest death rates (Belgium, Spain, Italy, UK, France, USA) had all orchestrated large vaccination campaigns specifically targeting their elderly population against the flu. Denmark and Germany, with lower use of the flu vaccine, have considerably lower COVID-19 mortality rates.

Although science should welcome data, and welcome any study shedding light to understand it meaningfully, looking at the possible correlation between the flu vaccination and the spread of the COVID-19 pandemic remains highly controversial: “Those who campaign against vaccination are campaigning against science. The science is settled…Those who have promoted the anti-vaccination myth are morally reprehensible, deeply irresponsible and have blood on their hands,” says British health secretary Matt Hancock.

In fact, instead of being "settled", the debate is raging! It has been shown that the onset of rheumatic disease after a number of vaccinations (including influenza, MMR, HBV, tetanus toxoid, typhoid, paratyphoid A and B (TAB), polio, diphtheria, and small pox) signifies that the vaccine may trigger persistent autoimmune response in genetically predisposed individuals, suggesting that they are at increased risk for rheumatic disease after vaccinations.(5)
In other words, vaccines can lower their immune defenses against diseases other than those covered by vaccination.
True scientific attitude presupposes an openness to the various hypotheses proposed. But conflicts of interest, the profitability of vaccination campaigns, and the political agendas of certain politicians are far more powerful levers than the scientific ethics which our "expert" lecturers seem to be entirely lacking.


On March 15th, as the first cases emerged, Dr. Anthony Fauci of the National Institute of Allergy & Infectious Diseases, predicted that 21 million Americans would be hospitalized with 1.7 million deaths. Three months later, less than 100,000 deaths have been reported, and this number is probably inflated, since many doctors have reported being “pressured” to classify many deaths as COVID-19, without any test being performed.(6)

No scientific evidence was needed for these terrifying numbers. Just like those hubristic economists before the 2008 global financial crisis, our health experts are now making mathematical models to fit their preconceived notions, indifferent to the economic and emotional carnage they are causing. The best we can do for now is to boost our immune system by going outside as much as possible (YES, fresh air is good for you!), enjoy the sun as much as you can (YES, Vitamin D deficiency weakens your immune system), and take two cones of RNA fragments a week (YES, they help create white blood cells and platelets, and have been shown in a clinical trial to be safe and effective even for vulnerable people under chemotherapy).(7) In my opinion is this is the best you can do to prepare your immune system to overcome anything, including any mandatory vaccination.


References


vitamin c banner

Vitamin C Benefits

Vitamin C is a water-soluble vitamin that humans are unable to synthesize. Vitamin C benefits for the body are vast. Since Vitamin C is essential to numerous enzymatic reactions, as well as a potent antioxidant, it is important to obtain it from the diet.

Studies in the 1970s and 1980s conducted by Nobel Prize winner Linus Pauling, and colleagues suggested that large doses of Vitamin C could be helpful to terminal cancer patients (1). Not surprisingly, and as anything else that is not expensive and seem to help cancer patients, controversy surrounding the efficacy of vitamin C in cancer treatment ensued.

Beside the use for cancer patients, Vitamin C has also been widely used for decades to boost immunity during cold and flu season or to treat viral infections. Indeed Vitamin C affects several components of the human immune system. In vitro, Vitamin C has been shown to stimulate both the production (2-6) and function (7,8) of leukocytes, those white blood cells which are at the core of our immune system and help us fight back when a threat is lurking.

A 2019 review article published in the European Journal of Microbiology and Immunology reports that the “potent antioxidant, immunomodulatory, and anti-infectious effects of Vitamin C have been known since the 1930s” and that Vitamin C has antimicrobial, antibacterial, antiviral, anti-parasitic and anti-fungal properties.

The Shanghai government in early March announced its official recommendation that COVID-19 should be treated with high doses of Vitamin C, from 4000 to 16,000 mg per day administered by IV. According to Dr. Richard Cheng, a US board-certified specialist in anti-aging medicine reporting from China, “Early and sufficiently large doses of intravenous Vitamin C are critical. Vitamin C is not only a prototypical antioxidant, but also involved in virus killing and prevention of viral replication.”

No, just like for the use of Vitamin C against cancer, it is pushing back against the use of Vitamin C against a virus.

On social media, there have been reports that the World Health Organization (WHO) has convened meetings with Facebook, Amazon, Google and more to stop coronavirus (COVID-19) “misinformation”. Information about the anti-infectious benefits of Vitamin C is listed as misinformation.

As reported in the January 2016 issue of Pharmaceutical Technology (9) only one-quarter of WHO’s funding comes from member states, while 75% of the WHO’s budget is from pharmaceutical companies and related interests, with The Bill & Melinda Gates Foundation being the biggest founder. Its donations even exceed those of any individual member state.

In 2017, India’s National Technical Advisory Group on Immunization (NTAGI) severed its ties with the Bill & Melinda Gates Foundation. According to India Times (10) “There were questions about the Gates Foundation’s ties with pharmaceutical companies and the possible influence this may have on the country’s vaccination strategy.” The Indian Health Ministry confirmed that the NTAGI would from there on be fully funded by the central government instead.

Today, we have Gates, a key founder of WHO, calling for a 10-week or longer shutdown of the U.S. and the rapid building of brand new vaccine manufacturing facilities to handle the manufacturing of billions of doses of the COVID-19 vaccine.

Who benefits and who loses by the implementation of those two recommendations?

Could that have anything to do with poo-pooing Vitamin C? Think about it.

Let us know your thoughts by contacting us here.

References

  1. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976;73(10):3685-3689. (PubMed)
  2. Jariwalla RJ, Harakeh S. Antiviral and immunomodulatory activities of ascorbic acid. In: Harris JR, ed. Subcellular Biochemistry. Vol. 25. Ascorbic Acid: Biochemistry and Biomedical Cell Biology. New York: Plenum Press; 1996:215-231.
  3. Kennes B, Dumont I, Brohee D, Hubert C, Neve P. Effect of vitamin C supplements on cell-mediated immunity in old people. Gerontology. 1983;29(5):305-310. (PubMed)
  4. Panush RS, Delafuente JC, Katz P, Johnson J. Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses. Int J Vitam Nutr Res Suppl. 1982;23:35-47. (PubMed)
  5. Prinz W, Bortz R, Bregin B, Hersch M. The effect of ascorbic acid supplementation on some parameters of the human immunological defence system. Int J Vitam Nutr Res. 1977;47(3):248-257. (PubMed)
  6. Vallance S. Relationships between ascorbic acid and serum proteins of the immune system. Br Med J. 1977;2(6084):437-438. (PubMed)
  7. Anderson R, Oosthuizen R, Maritz R, Theron A, Van Rensburg AJ. The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in normal volunteers. Am J Clin Nutr. 1980;33(1):71-76. (PubMed)
  8. Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F. Vitamin C for the treatment of recurrent furunculosis in patients with impaired neutrophil functions J. Infect Dis. 1996;173(6):1502-1505. (PubMed)
  9. Pharmaceutical Technology January 1, 2016; 40(1): 16-17
  10. India Times February 9, 2017

How To Stay Healthy During COVID-19

Dear Clients & Friends,
While our country is in the middle of an unprecedented healthcare challenge, we here at The Beljanski Foundation wanted to reach out to you in hopes that you, your family, and loved ones are all well during the COVID-19 (coronavirus) pandemic.
More than ever, we want to reaffirm our commitment to provide you with information and support to help you maintain and even improve your well-being.

For almost 40 years, the late Prof. Mirko Beljanski studied DNA and RNA biology and made numerous discoveries, providing great scientific contributions to our understanding of basic life processes, cancer, viral illnesses and autoimmune diseases. His work also has major practical implications in supporting normal physiological functions and improving one’s health.

Dr. Mirko Beljanski’s research provided us with a three step approach to fight viruses:

  1. Strengthen the Immune System
  2. Inhibit Viral Duplication
  3. Destruction of Infected Cells

Pathogens range from viruses to parasitic worms and sometimes they change themselves (mutate) to keep infecting and replicating in their hosts despite treatments.

When we encounter a pathogen, whatever it is, we want to keep it outside our bodies. Our skin is our first line of defense. Hence the recommendation of washing our hands.

Then comes the other physical barriers -- that will help us destroy the pathogen (stomach acid), or help us expel it (tears, mucus).

But sometimes, the invader makes its way within. Your immune system is then called to the rescue. Its job is to protect you against harmful pathogens (like bacteria and viruses), and limit damage from noninfectious agents (like sunburn or cancer). But what if you don’t have a strong immune system? This is why all whose immune systems are weakened, including adults and children with serious chronic health conditions (including cancer) are at greater risk of developing serious complications from COVID-19 (coronavirus).

The immune system is composed of a variety of cells and cell signals, working together to prevent and cure infections. All of these immune cells derive from stem cells in the bone marrow.

Individuals undergoing chemotherapy often see their white blood cells damaged by the treatment, leading to the weakening of their immune systems. As Dr. Mirko Beljanski was looking into helping individuals whose white blood cells have been damaged by chemotherapy, he developed small RNA fragments that can prime the replication of DNA in bone marrow stem cells. The bone marrow, in turn, creates all the lines of white blood cells that soldier our immune system. In a clinical trial at Cancer Treatment Centers of America (CTCA), where the studied population was cancer patients with very weakened immunity, these RNA fragments proved to be a breakthrough: no toxicity, no side effects, and a better immune system.

Viruses are perfect parasites. Outside a living cell, a virus is a dormant particle, not able to reproduce itself. Only when it enters a host cell, it goes into action by hijacking the cellular processes. DNA viruses (like the poxvirus) can replicate in the host cell. RNA viruses, including COVID-19, need to infect cells by injecting RNA into the cytoplasm of the host cell and then using their own transcription enzyme (reverse transcriptase) to create DNA from viral RNA templates. From then on, the infected cell will produce virally encoded protein that will replicate the virus’s genetic material and generate new viruses.

As a young researcher, Dr. Mirko Beljanski spent several years working with 1959 Nobel Prize Winner Severo Ochoa. Ochoa was recognized for his discovery of an enzyme in bacteria called polynucleotide phosphorylase, which catalyzed the synthesis of ribonucleic acid (RNA). This work led Mirko Beljanski to further study, and eventually to re-create the conditions whereby the hereditary information contained in genes is translated. (2) In the process, he showed how some metals may inhibit or stimulate the reverse transcriptase enzyme. (3)

Metals are indispensable for DNA synthesis and a host of metabolic processes. Iron in particular is necessary for blood oxygenation. A depletion in iron prevents proper enzymatic activity and leads to anemia. But too much iron will promote reverse transcriptase activity, leading to increased viral duplication. Excess iron can also promote cancer cell growth.

Heavy metals are a common source of toxicity. They are in many of the products we use every day, including the water we may drink. When fighting a viral pandemic, it is time to limit any chance of heavy metal overload. It is actually a perfect time to consider a good heavy metal detoxification through oral chelation.

In the 1980s, Dr. Beljanski studied an extract of Pao pereira (Pau pereira, at the time called “PB-100” Produit Beljanski 100mg), made from the bark of a tree that grows in the Amazon Rain Forest.

Dr. Beljanski showed that Pao pereira (Pau pereira) could inhibit the replication of RNA viruses, in different species, ranging from plants (TMV), to birds (AEV) and cats (FIV). (4) That led him to work on the human immunodeficiency virus (HIV), also an RNA virus. The results of a clinical trial performed on people infected with HIV and treated orally with PB-100 for 12 months, were published in 1994. This study demonstrated the safety of the extract, the improvement of lymphocyte sub-populations (T4 / T8 ratio), as well as other positive indications. (5)

This broad spectrum anti-viral action results from inhibition of reverse transcriptase in those cells infected by the RNA viruses. COVID-19 (coronavirus) is known to be an RNA virus, but no study has been made possible at this time to test the effectiveness of Pao pereira (Pau pereira).

Since Dr. Mirko Beljanski published his results on the antiviral activity of Pao pereira (Pau pereira) in 1985, (6) numerous people have either tried to negate the discovery or unduly pretend they were part of the story. Since then, The Beljanski Foundation, through partnerships with various academic institutions, has obtained confirmation that Pao pereira (Pau pereira) also exhibits a broad spectrum of anti-cancer activity. (7, 8, 9, 10, 11)

For nearly 25 years, we’ve have built a brand with the intent to serve our greater community of employees, family, and friends when they need us most – whenever, wherever they are.

Please know that we are thinking of you as we are all in this together.

Stay healthy & stay safe,

Sylvie Beljanski

References

  1. “Dose Escalation Study of an Antithrombocytopenic Agent in Patients with Chemotherapy Induced Thrombocytopenia”. Robert D Levin, MaryAnn Daehler, James F Grutsch, John L Hall, Digant Gupta, Christopher G Lis. Levin Online magazine Bio Med Central BMC Cancer 10:565 – 2010.
  2. M. BELJANSKI, “De Novo Synthesis of DNA – Like Molecules by Polynucleotide Phosphorylase In Vitro". J. Mol. Evol. 1996, 42:493-499.
  3. “Differential effects of ferritin, calcium, zinc and gallic acid on in vitro proliferation of human glioblastoma cells and normal astrocytes”. M. BELJANSKI, S. CROCHET J. Lab. Clin. Med. 123:547-555, 1994.
  4. M. Beljanski. « La Prévention ». Les Entretiens Internationaux de Monaco. Editions du Rocher, 1990.
  5. “Tolerance and Feasibility of a 12-Month Therapy Using the Antiretroviral Agent PB100 in AIDS-Related Complex Patients”. D.Donadio et al. Dtsch.Zschr.Onkol.26, 6 (1994).
  6. European Patent 0 059 817, October 9, 1985.
  7. “β-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells”. Debra L. Bemis, PhD, Jillian L. Capodice, LAc, MS, Manisha Desai, PhD, Aaron E. Katz, MD, Ralph Buttyan, PhD – Journal of the Society for Integrative Oncology, Vol 7, No2
  8. “Pao pereira Extract Suppresses Castration- Resistant Prostate Cancer Cell Growth, Survival and Invasion Through Inhibition of NFkB Signaling”. Cunjie Chang, BS, Wei Zhao, MS, Bingxian Xie, BS, Yongming Deng, BS, Tao Han, BM, Yangyan Cui, BS, Yundong Dai, BS, Zhen Zhang, BS, Jimin Gao, MD, PhD, Hongqian Guo, MD, PhD, and Jun Yan, PhD. Integr Cancer Ther. 2014 May;13(3):249-58. Doi: 10.1177/1534735413510557. Epub 2013 Nov 27
  9. “Antitumor Activities of Rauwolfia Vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer”. Yu J, Ma Y, Drisko J, Chen Q. Curr Ther Res Clin Exp. 2013 Dec;75:8-14. doi: 10.1016/j.curtheres.2013.04.001.
  10. “Inhibition of Pancreatic Cancer and Potentiation of Gemcitabine Effects by the Extract of Pao Pereira”. JUN YU, JEANNE DRISKO and QI CHEN Oncology Reports” Journal (doi: 10.3892/or.2013.2461)
  11. “Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo”. Ruochen Dong, BS, Ping Chen, MS, Qi Chen, PhD

Hydroxychloroquine as Potential COVID-19 Treatment?

Hydroxychloroquine to Treat COVID-19?

With the very public announcement that an old anti-malaria drug could be effective against the coronavirus (COVID-19), everybody is re-discovering this disease, which has been for centuries, probably the most serious health problem facing northern Amazonia.

Malaria is a disease caused by a parasite of the genus Plasmodium and transmitted to humans through the bites of infected mosquitoes. People who have the disease usually have a high fever and shaking chills. Despite an 18% global decrease in malaria occurrence between 2010 and 2017, an estimated 3.4 billion people in 92 countries are at risk of being infected and the disease is often fatal.

Now, the World Health Organization is sponsoring a large international clinical trial called SOLIDARITY to study six drugs that could be rapidly deployed for the fight against the coronavirus (COVID-19), including hydroxychloroquine, a seventy year old anti-malarial drug.

hydroxychloroquine, covid19
Image from:
https://www.theguardian.com/world/2020/apr/06/hydroxychloroquine-trump-coronavirus-drug

Chloroquine phosphate was discovered in 1934 as a superior drug than quinine to treat malaria. In 2004 it was identified as an inhibitor of the SARS coronavirus. The frenzy about hydroxychloroquine (a Chloroquine derivative thought to have less severe side effects) started with a declaration on March 16 from Dr. Didier Raoult, director of a university hospital institute in Marseille, France’s second city, regarding the successful testing of hydroxychloroquine for use against the coronavirus (COVID-19).

In a press conference, Dr. Raoult presented the results of a clinical trial in which he treated 25 coronavirus (COVID-19) patients with this drug. “After six days,” he said, “only 25 percent of patients who took this drug still had the virus in their body. By contrast, 90 percent of those who had not taken hydroxychloroquine continued to carry the COVID-19.”

Didier-Raoult
Professor Didier Raoult

In light of the long record of use of hydroxychloroquine again Malaria, it is very tempting to jump ahead and claim that we have a cure against the coronavirus (COVID-19). It is obviously President’s Trump hope, as he is looking for ways to send America back to work as soon as possible. Not so fast! “We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good,” said FDA Commissioner Stephen Hahn, speaking at a press briefing, minutes after the President’s announcement.

Indeed, dosage and toxicity issues, along with side effects, are quite common with drugs. However, there is such a big, organized, push back against a drug which has been around for decades, that one can’t help but to “follow the money”, and wonder who would be the winners and the losers if hydroxychloroquine is ever recognized as a cure to the coronavirus (COVID-19).

Potential Controversy of Hydroxychloroquine?

No doubt that pharmaceutical companies would not make a lot of money on it, because it is an old drug already produced as a generic. In the eyes of pharmaceutical companies this is a major impediment, and they obviously have lobbied hard with some politicians to push back against the drug. Many politicians being just too happy to oppose President Trump, they welcome and parrot the arguments provided by the pharmaceutical companies.

And that’s how the collusion of money and power leads to a controversy, even though everybody is short of scientific evidence to back their position.

Some doctors specialized in infectious and tropical diseases, and who are familiar with hydroxychloroquine, have reported that it seems to destroy the virus, but in doing so, it also brings major disruption to the DNA of the patient. A little bit like a chemotherapy, that destroys everything, good and bad cells. Ocular toxicity, heart risk concerns, and hepatic dysfunction have also been reported as long-term effects with patients using the drug against malaria or lupus, but for the patient fighting the coronavirus (COVID-19) and under a ventilator, long term effects are probably not a huge concern.

So far there are a number of anecdotal evidence showing that when used for a short period, hydroxychloroquine may deliver the immediate response patients are looking for. In the meantime, pharmaceutical companies are advancing new molecules that they can patent and make serious money on. Chances are that several molecules will be approved by the FDA, and then it will be all about marketing. That’s where the generic drug will lose its market share to the newbies.

Pao Pereria: Natural Solution WITHOUT Side Effects

Pao pereira, ©The Beljanski Foundation, Inc.

However, it is important to remember that for patients who are not in extreme condition, there are natural solutions, much more gentle, which are out there, with similar properties. For example, the stem bark of Pao pereira has been used for centuries by the native population of northern South America to treat malaria. Thanks to The Beljanski Foundation, a New York based non-profit whose mission is to study the health benefits of some natural molecules, Pao pereira’s anti-cancer effects are well documented, and there is published evidence that the extract has an antiviral effect, as well as an anti-inflammatory benefit.

Contact us here if you have any questions about Pao pereira.


covid19 banner

Doctors Turn to Malaria Drugs as Potential Coronavirus Treatment

Malaria, Coronavirus Treatment & Pao Pereira

With the announcement by the Wall Street Journal, that an old anti-malaria drug could be effective coronavirus treatment, everybody is re-discovering this disease, which has been for centuries, probably the most serious health problem facing northern Amazonia.

coronavirus treatment

Malaria is a disease caused by a parasite of the genus Plasmodium transmitted to humans through the bites of infected mosquitoes. People who have the disease usually have a high fever and shaking chills. Despite an 18% global decrease in incidences of malaria between 2010 and 2017, an estimated 3.4 billion people in 92 countries are at risk of being infected with malaria and developing the disease. The disease is often fatal, especially considering that the disease is preponderant where access to good quality medicines including malaria drugs is highly uneven.

Now doctors and hospitals are testing a seventy year old antimalarial drugs on patients infected with the new coronavirus.

It all started with a declaration on March 16 from Dr. Didier Raoult, director of a University Hospital Institute in Marseille, France’s second city, regarding the successful testing of hydroxychloroquine for use as a coronavirus treatment. Hydroxychloroquine has been used for around 70 years to treat malaria, and its patent has long expired. A new patent would provide a new commercial life to this old molecule.

In a press conference, Dr. Raoult presented the results of a clinical trial in which he treated 25 COVID-19 patients with this drug. “After six days,” he said, “only 25 percent of patients who took this drug still had the virus in their body. By contrast, 90 percent of those who had not taken hydroxychloroquine continued to carry the COVID-19.”

Professeur Didier Raoult, coronavirus treatment

In light of the long record of use of hydroxychloroquine against Malaria, it is very tempting to jump ahead and claim that we have a cure against the coronavirus. Not so fast! “We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good,” said FDA Commissioner Stephen Hahn, speaking at a press briefing with the president and other officials.

Indeed, dosage and toxicity issues, along with side effects, are quite common with drugs. Not so much with natural extracts. And it so happens that the stem bark of Geissospermum vellosii, common name: Pao pereira, has been used for centuries by the native population of northern South America to treat malaria. A few years ago, I devoted an entire blog to the subject of the traditional use of Pao pereira.

In 1879, the journal Medical Times (Vol. X p. 276 – Philadelphia) published a two-page article devoted to the very satisfactory results obtained with the use of Pao pereira and quoting Dr. Torres Homem, Professor of Clinical Medicine at the Academy of Rio de Janeiro “There is not a doctor in Brazil who has not obtained good results from the use of this bark in the treatment of intermittent fevers.”

In 1887, in “le Journal de Médecine, de Chirurgie et de Phamacologie” (Bruxelles) published in “Nouveaux remèdes” the following note: “the alkaloid pereirine would be more effective than quinine against malarial fevers.”

Since then, Pao pereira, has been extensively studied by French scientist Mirko Beljanski for its anti-cancer and anti-viral properties.

Nowadays, the Pao pereira extract is available as a dietary supplement and The Beljanski Foundation has developed numerous scientific partnerships with several scientific institution confirming the activity of the extract on different cancer cell lines including prostate, ovaries, and pancreas, and even on cancer stem cells, linked to metastasis.

Stay home, stay safe & stay healthy,

Sylvie Beljanski
Vice President, The Beljanski Foundation